Brief: Oncosil Medical Says Fully-Funded Trial Approved In Germany
28/03/2022 02:56
March 28 (Reuters) - Oncosil Medical Ltd OSL.AX :
* FULLY-FUNDED TRIAL APPROVED IN GERMANY-OSL.AX
* FEDERAL JOINT COMMITTEE (G-BA) APPROVED FULLY-FUNDED
TRIAL IN
GERMANY TO ASSESS ONCOSIL DEVICE COMPARED WITH CHEMOTHERAPY
Source text for Eikon: ID:nASX2rm86C
Further company coverage: OSL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncosil Medical
See all newsAustralia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone
Brief: Oncosil Medical Says FDA Grants Hde Approval For Oncosil Device For Distal Cholangiocarcinoma
Brief: Oncosil Medical Posts FY26 Unit Sales Up 53%, Revenue Up 44% Versus FY25
Brief: Oncosil Medical Receives Saudi FDA Approval
Brief: Oncosil Medical Files For FDA Approval